Pulmonary & Nasal Resources From Kindeva Drug Delivery’s Experts
With over a century of experience and a rich legacy of firsts, Kindeva Drug Delivery is a global leader in pulmonary & nasal combination products. We invented the first metered-dose inhaler and continue to lead the way in innovation, optimizing the shift to more eco-friendly options with low-GWP propellants. Take a deep dive into the latest developments from Kindeva to discover how we are navigating these changes while preserving patient experience and maintaining regulatory compliance.
Ensure reliability and quality for your pMDI products amidst the shift to more eco-friendly propellants. This webinar covers differences between propellant properties and offers tips for preserving product performance.
While the transition to next-generation green propellants improves sustainability, it is essential to ensure patient experience is not diminished as a result. In this webinar, learn how differences in propellant properties impact pMDI performance and uncover a diverse array of investigations and methods to explore these effects.
The shift to greener propellant option brings new regulatory considerations. Are you prepared? In this short video, uncover key considerations for navigating these regulations.
How do proposed green propellant regulations affect the industry, and how can companies best adapt? Find out in this short video and hear projections for the future of eco-friendly propellants.
Considering proposed legislation to improve the eco-friendliness of inhalers, it is essential to balance the needs of patients and the planet. In this article, we provide an overview of the impacts of a switch to green propellants and consider how to best ensure a consistent patient experience.
